Drug Database
Back to search

Iceland· IS-EU/1/09/511/01-05

Conbriza

A bazedoxifene product containing bazedoxifenum inn asetat, registered in Iceland by Pfizer Europe MA EEIG*. The same ATC class is registered in 10 of our 19 countries.

ATC G03XC02

Checked against Icelandic Medicines Agency (Iceland) on

Informational only — not a medical device.

SOURCE REGISTER · ISIcelandic Medicines Agency (Iceland)normalisedConbrizaATCG03XC02REGISTER NO.IS-EU/1/09/511/01-05PACKS LISTED0CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about bazedoxifenum inn asetatAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Bazedoxifene is registered in 10 of 19 countries.

Countries holding a registration under ATC G03XC02 (bazedoxifene), each read from that country’s own register.

  • This record: Iceland, from Icelandic Medicines Agency (Iceland)
  • 6 of them publish a price we can compare per daily dose
Search bazedoxifene products by name

Bazedoxifene · ATC G03XC02

10 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of bazedoxifene costs, country by country.

Normalised to the WHO defined daily dose (20 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Bazedoxifene · price per daily dose (20 mg)

USD · FX 28 Sept 2026

  • IT Italy$1.34
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Icelandic Medicines Agency (Iceland)
Active substance
Bazedoxifenum INN asetat
Manufacturer
Pfizer Europe MA EEIG*
Country
Iceland (IS)
ATC code
G03XC02
ATC class
Bazedoxifene
Defined daily dose
20 mg, O
Reimbursed
Not published by this register
Source register
Icelandic Medicines Agency (Iceland)
Last checked
September 29, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

6 interactions on record for bazedoxifene.

Graded by severity as the source publishes them — 6 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check bazedoxifene against other medicinesHow interaction checks work

Bazedoxifene · interactions on record

6 records

  • 6 moderate

Most severe, free to view

  • MegestrolG03AC05moderate
  • MedroxyprogesteroneG03AC06moderate
  • MedroxyprogesteroneG03DA02moderate
  • MegestrolG03DB02moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Bazedoxifene in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All bazedoxifene products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

  • Liechtenstein · Conbriza
  • Norway · Conbriza

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b8dafb18-85b4-4ccc-aca5-a81922e87f5c
GET /v1/drugs/b8dafb18-85b4-4ccc-aca5-a81922e87f5c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmuhúðuð tafla",
  "source": "lyfjastofnun",
  "atc_raw": "G03XC02",
  "marketed": false,
  "strength": "20 mg",
  "ma_number": "EU/1/09/511/01-05",
  "substance": "Bazedoxifenum INN asetat",
  "other_info": null,
  "legal_status": "(R) Lyfseðilsskylt",
  "ma_issued_serial": "39989"
}
API referenceMCP serverPlans

See everything about bazedoxifene.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console